A new national study finds GLP-1 weight-loss medications are becoming the dominant treatment for obesity in teens and young adults, while researchers say guidance on how to use these therapies is still evolving.
Health News is provided as a service to Nipomo Rexall Drug site users by HealthDay. Nipomo Rexall Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.